Can B (CANB) EBIT per Share : $-0.24 (TTM As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Can B EBIT per Share?

Can B's EBIT per Share for the three months ended in Sep. 2024 was $-0.04. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.24.

During the past 3 years, the average EBIT per Share Growth Rate was 73.50% per year. During the past 5 years, the average EBIT per Share Growth Rate was 55.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Can B's EBIT per Share or its related term are showing as below:

CANB' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -60.8 Med: 5.9 Max: 73.5
Current: 73.5

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Can B was 73.50% per year. The lowest was -60.80% per year. And the median was 5.90% per year.

CANB's 3-Year EBIT Growth Rate is ranked better than
96.13% of 827 companies
in the Drug Manufacturers industry
Industry Median: 8.1 vs CANB: 73.50

Can B's EBIT for the three months ended in Sep. 2024 was $-2.83 Mil.

Can B EBIT per Share Historical Data

The historical data trend for Can B's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Can B EBIT per Share Chart

Can B Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-32.91

-33.65

-7.50

-3.93

-0.57

Can B Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															-0.31	-0.02	-0.15	-0.03	-0.04

Can B EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Can B's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-7.217	/	12.590
=	-0.57

Can B's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2.832	/	65.436
=	-0.04

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.24

Can B (OTCPK:CANB) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Can B EBIT per Share Related Terms

Thank you for viewing the detailed overview of Can B's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Can B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Can B Corp (OTCPK:CANB) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

960 South Broadway, Suite 120, Hicksville, NY, USA, 11801

Website

https://www.canbiola.com

Can B Corp is engaged in the business of promoting health and wellness through its development, manufacture and sale of products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. The company focuses on developing a line of proprietary products in the Hemp Industry.

Executives

Mckenzie Webster Ltd	10 percent owner	DMS HOUSE, DR. ROYCE DRIVE, GEORGE TOWN, GRAND CAYMAN E9 KY1-1102
Stanley L Teeple	director, officer: CFO, Director, and Secretary	94 ARTHUR HILL COURT, HENDERSON NV 89014
Andrew Holtmeyer	officer: EVP Business Development	65 LAUREN AVE, SUITE 301, HUNTINGTON STATION NY 11746
Heggenhougen Rolv	director	90 NORTH CHURCH STREET, GEORGETOWN E9 KY1-1102
David J Posel	officer: COO	6103 CARMEL LN SE, LACEY WA 98503
Rolv Heggenhougen	10 percent owner	445 NE 12TH AVENUE, FORT LAUDERDALE FL 33301
Marco Alfonsi	director, 10 percent owner, officer: CEO, Board Member	44 EAST END AVENUE, HICKSVILLE NY 11801
Carl Dilley	director	15500 ROOSEVELT BLVD., SUITE 301, CLEARWATER FL 33760